Work

607 NCIC CTG IND.196: Phase I Study of Foretinib (GSK1363089) and Erlotinib in Patients with Advanced Pretreated NSCLC

Year: 2012

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(12)72404-8

Authors: N.B. Leighl, M.S. Tsao, C. Ho, F.A. Shepherd, N. Murray, J. Goffin, G. Nicholas, L. Seymour, G.D. Goss, P. Bradbury

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2087755767

FWCI:

Cites:

Cited by:

Related to: 10